Abstract
Cardiovascular disease (CVD) is a leading cause of mortality and is responsible for one-third of all global deaths annually. This translates into the deaths of 17 million people each year [1, 2]. Despite research-based gains in the treatment of CVDs, they remain the leading killer in the USA and in most developed areas of the world. Coronary heart disease (CHD) accounts for the majority of CVD deaths, disproportionately afflicts racial and ethnic minorities, and is a prime target for prevention. Hypertension is the most prevalent CVD, affecting at least 600 million people, and is an important contributor to cardiovascular mortality and morbidity [3]. Nearly 85% of the global mortality and disease burden from CVD is borne by low- and middle-income countries.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Mathers CD, Stein C, Ma Fat DM et al (2002) Global burden of disease 2000. Version 2: methods and results. World Health Organization, Geneva
World Health Organization (2002) The World Health Report 2002 ‘Reducing risks and promoting healthy life’. World Health Organization, Geneva
Mensah GA (2002) The global burden of hypertension: good news and bad news. Cardiol Clin 20(2):181–185
Yusuf S, Reddy S, Ounpuu S, Anand S (2001) Global burden of cardiovascular diseases. Part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104:2746–2753
Yusuf S, Reddy S, Ounpuu S, Anand S (2001) Global burden of cardiovascular diseases. Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 104:2855–2864
Alwan A, Maclean D, Mandil A (2001) Assessment of national capacity for noncom-municable disease prevention and control. The report of a global survey. World Health Organization, Geneva
World Health Organization (2001) Innovative care for chronic conditions. World Health Organization, Geneva
Klungel OH, de Boer A, Paes AH et al (1998) Undertreatment of hypertension in a population-based study in the Netherlands. J Hypertens 9:1371–1377
Hedner T (1998) Treating hypertension — effect of treatment and cost-effectiveness in respect to later cardiovascular diseases. Scand Cardiovasc J 47:S31–S35
Trilling JS, Froom J (2000) The urgent need to improve hypertension care. Arch Fam Med 9:794–801
Pocock SJ, McCormack V, Gueyffier F et al (2001) A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ 2001 323:75–81
World Health Organization (2001) Adherence to long-term therapies: policy for action. World Health Organization, Geneva
Feldman R, Bacher M, Campbell N, Drover A, Chockalingam A (1998) Adherence to pharmacologic management of hypertension. Can J Public Health 89(5):116–118
Van Den Hoogen PCW, Feskens EJM, Nagelkerke NJD et al for the Seven Countries Study Research Group (2000) The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. N Engl J Med 342:1–8
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Italia
About this paper
Cite this paper
Boni, A., Lorenzoni, R., Lazzari, M., Gemignani, C., Bovenzi, F. (2007). Cardiovascular Risk Management: An Overview. In: Gulizia, M.M. (eds) Current News in Cardiology. Springer, Milano. https://doi.org/10.1007/978-88-470-0636-2_50
Download citation
DOI: https://doi.org/10.1007/978-88-470-0636-2_50
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0635-5
Online ISBN: 978-88-470-0636-2
eBook Packages: MedicineMedicine (R0)